Insurers Invest in Generative AI, but Long-Term Impact Remains Uncertain
Health insurers, like most companies, are experimenting with how to incorporate artificial intelligence into their work processes to help them make more timely decisions, cut costs, improve profitability and help members. While it is still early to assess how AI will be most effective, plans should make sure they apply AI in an ethical manner and involve multiple stakeholders in any efforts, according to three executives who spoke during a July 26 webinar sponsored by consulting firm ZS.
Onyinyechi Daniel, Ph.D., who until recently was Highmark Health’s vice president of data and analytics strategy, noted that using AI was “nothing new” for employees in companies’ data and analytics departments. But she added that “the onset of generative AI brought a lot more visibility and really amplified efforts,” especially among executives who are leading the charge in pushing for the adoption of AI throughout their organizations.
Meet Our Reporters
-
Lauren Flynn Kelly Executive Editor, AIS Health, and Managing Editor, Radar on Medicare Advantage
View Lauren Flynn Kelly's Profile -
Angela Maas Managing Editor, Radar on Specialty Pharmacy and Spotlight on Market Access
View Angela Maas's Profile -
Leslie Small Managing Editor, Health Plan Weekly and Radar on Drug Benefits
View Leslie Small's Profile -
Tim Casey Reporter, Health Plan Weekly and Radar on Drug Benefits
View Tim Casey's Profile -
Carina Belles Reporter, Radar on Medicare Advantage and Spotlight on Market Access
View Carina Belles's Profile -
Jinghong Chen Reporter, Health Plan Weekly and Radar on Drug Benefits
View Jinghong Chen's Profile
